Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation.

Wei J, Xu G, Wu M, Zhang Y, Li Q, Liu P, Zhu T, Song A, Zhao L, Han Z, Chen G, Wang S, Meng L, Zhou J, Lu Y, Wang S, Ma D.

Anticancer Res. 2008 Jan-Feb;28(1A):327-34.

2.

[Effects of vimentin on invasion and metastasis of prostate cancer cell lines PC-3M-1E8 and PC-3M-2B4].

Wei JC, Wu MF, Zhang YT, Zhao LP, Lu YP, Ma D.

Ai Zheng. 2008 Jan;27(1):30-4. Chinese.

PMID:
18184460
3.

Vimentin affects the mobility and invasiveness of prostate cancer cells.

Zhao Y, Yan Q, Long X, Chen X, Wang Y.

Cell Biochem Funct. 2008 Sep-Oct;26(5):571-7. doi: 10.1002/cbf.1478.

PMID:
18464297
4.

Proteome analysis of human androgen-independent prostate cancer cell lines: variable metastatic potentials correlated with vimentin expression.

Wu M, Bai X, Xu G, Wei J, Zhu T, Zhang Y, Li Q, Liu P, Song A, Zhao L, Gang C, Han Z, Wang S, Zhou J, Lu Y, Ma D.

Proteomics. 2007 Jun;7(12):1973-83.

PMID:
17566973
5.
6.

N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.

Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, Kawaguchi Y, Fujimoto K, Hosotani R, Imamura M.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4125-33.

7.

Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.

Horvath LG, Lelliott JE, Kench JG, Lee CS, Williams ED, Saunders DN, Grygiel JJ, Sutherland RL, Henshall SM.

Prostate. 2007 Jul 1;67(10):1081-90.

PMID:
17476687
8.
9.

Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells.

Luo Y, He DL, Ning L, Shen SL, Li L, Li X.

Chin Med J (Engl). 2006 May 5;119(9):713-8.

PMID:
16701010
11.

[Expression and significance of metastasis-associated proteins in prostate cancer cell lines with different metastatic potentials].

Luo Y, He DL, Ning L, Zhu GD, Shen SL.

Zhonghua Nan Ke Xue. 2006 Mar;12(3):230-3. Chinese.

PMID:
16597039
12.

[Transforming growth factor beta upregulates the expression of invasion and metastasis associated proteins in prostate cancer LNCaP cell lines in vitro].

Zhu GF, Cheng HP, Wu KJ, Zhang LL, Zhu GD, Zhang D, He DL.

Zhonghua Nan Ke Xue. 2008 Mar;14(3):238-41. Chinese.

PMID:
18488338
14.

Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.

Wu K, Zeng J, Li L, Fan J, Zhang D, Xue Y, Zhu G, Yang L, Wang X, He D.

Oncol Rep. 2010 Jun;23(6):1545-52.

PMID:
20428808
15.

Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.

Veveris-Lowe TL, Lawrence MG, Collard RL, Bui L, Herington AC, Nicol DL, Clements JA.

Endocr Relat Cancer. 2005 Sep;12(3):631-43.

PMID:
16172196
16.

[Over-expression of HIF-1alpha induces EMT of human prostate cancer cells].

Luo Y, He DL, Jiang YG, Li MC, Ning L, Shen SL.

Zhonghua Nan Ke Xue. 2008 Sep;14(9):800-4. Chinese.

PMID:
18998463
17.

FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.

Li Y, Zhu X, Zeng Y, Wang J, Zhang X, Ding YQ, Liang L.

Mol Cancer Res. 2010 Dec;8(12):1579-90. doi: 10.1158/1541-7786.MCR-10-0081. Epub 2010 Nov 11.

18.

Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.

Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP.

Clin Cancer Res. 2000 May;6(5):2104-19.

19.

Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.

Murali AK, Norris JS.

J Urol. 2012 Aug;188(2):632-8. doi: 10.1016/j.juro.2012.03.114. Epub 2012 Jun 15.

PMID:
22704442
20.

Roles of vimentin and 14-3-3 zeta/delta in the inhibitory effects of heparin on PC-3M cell proliferation and B16-F10-luc-G5 cells metastasis.

Pan Y, Zhong LJ, Zhou H, Wang X, Chen K, Yang HP, Xiaokaiti Y, Maimaiti A, Jiang L, Li XJ.

Acta Pharmacol Sin. 2012 Jun;33(6):798-808. doi: 10.1038/aps.2012.42.

Supplemental Content

Support Center